After two weeks of intermittent fasting, certain muscle signaling molecules changed—GSK became more active and mTOR less active—but these didn’t translate into changes in how the body used sugar or muscle protein overall.
Scientific Claim
Intermittent fasting for 2 weeks increases phosphorylation of glycogen synthase kinase (GSK) and decreases phosphorylation of mammalian target of rapamycin (mTOR) in skeletal muscle of lean healthy adults, but these changes are not linked to altered whole-body glucose or protein metabolism.
Original Statement
“IF had no effect on the phosphorylation of AKT but significantly increased the phosphorylation of glycogen synthase kinase. Phosphorylation of mTOR was significantly lower after IF than after the SD. IF does not affect whole-body glucose, lipid, or protein metabolism in healthy lean men despite changes in muscle phosphorylation of GSK and mTOR.”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The abstract implies causation between IF and phosphorylation changes, but without blinding or control for confounders (e.g., timing of biopsy, activity), only association can be claimed. The link to metabolism is observational.
More Accurate Statement
“Intermittent fasting for 2 weeks was associated with increased phosphorylation of glycogen synthase kinase and decreased phosphorylation of mammalian target of rapamycin in skeletal muscle of lean healthy adults, without corresponding changes in whole-body glucose, lipid, or protein metabolism.”
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1bCausal effect of intermittent fasting on muscle GSK and mTOR phosphorylation and whether these changes are independent of systemic metabolism.
Causal effect of intermittent fasting on muscle GSK and mTOR phosphorylation and whether these changes are independent of systemic metabolism.
What This Would Prove
Causal effect of intermittent fasting on muscle GSK and mTOR phosphorylation and whether these changes are independent of systemic metabolism.
Ideal Study Design
A double-blind, randomized crossover RCT with 25 lean healthy adults, each undergoing 2 weeks of IF and 2 weeks of SD, with muscle biopsies taken at identical time points post-fast and during clamp, measuring GSK and mTOR phosphorylation via Western blot, alongside whole-body metabolic fluxes.
Limitation: Muscle biopsy sampling is invasive and may not reflect whole-body signaling dynamics.
Prospective CohortLevel 2bLongitudinal association between habitual IF and muscle signaling changes in free-living individuals.
Longitudinal association between habitual IF and muscle signaling changes in free-living individuals.
What This Would Prove
Longitudinal association between habitual IF and muscle signaling changes in free-living individuals.
Ideal Study Design
A 12-month cohort study of 100 adults practicing intermittent fasting ≥3 days/week, with muscle biopsies and metabolic assessments at baseline, 3, 6, and 12 months, controlling for protein intake and training status.
Limitation: Cannot control for adherence variability or confounding lifestyle factors.
Cell Culture StudyLevel 5Direct molecular mechanism by which fasting conditions alter GSK and mTOR phosphorylation in human muscle cells.
Direct molecular mechanism by which fasting conditions alter GSK and mTOR phosphorylation in human muscle cells.
What This Would Prove
Direct molecular mechanism by which fasting conditions alter GSK and mTOR phosphorylation in human muscle cells.
Ideal Study Design
Human primary myotubes exposed to serum-free media mimicking fasting (low insulin/glucose) vs. fed conditions, measuring GSK and mTOR phosphorylation over 24–72 hours, with inhibitors to test pathway dependence.
Limitation: Cannot replicate systemic hormonal, neural, or nutritional interactions present in vivo.
Evidence from Studies
Supporting (1)
Intermittent fasting does not affect whole-body glucose, lipid, or protein metabolism.
The study found that skipping meals for two weeks changed certain muscle signals (GSK and mTOR) but didn’t affect how the body uses sugar or protein overall — exactly what the claim says.